133 related articles for article (PubMed ID: 29417620)
1. HER2 Ile655Val polymorphism is negatively associated with breast cancer susceptibility.
de Almeida FC; Banin Hirata BK; Ariza CB; Losi Guembarovski R; de Oliveira KB; Suzuki KM; Guembarovski AL; Oda JMM; Vitiello GAF; Watanabe MAE
J Clin Lab Anal; 2018 Jul; 32(6):e22406. PubMed ID: 29417620
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 7 receptor alpha Thr244Ile genetic polymorphism is associated with susceptibility and prognostic markers in breast cancer subgroups.
Vitiello GAF; Losi Guembarovski R; Amarante MK; Ceribelli JR; Carmelo ECB; Watanabe MAE
Cytokine; 2018 Mar; 103():121-126. PubMed ID: 28964592
[TBL] [Abstract][Full Text] [Related]
3. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
[TBL] [Abstract][Full Text] [Related]
4. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
Anticancer Res; 2015 Dec; 35(12):6667-70. PubMed ID: 26637882
[TBL] [Abstract][Full Text] [Related]
5. Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer.
Han X; Diao L; Xu Y; Xue W; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Ann Oncol; 2014 Jun; 25(6):1158-64. PubMed ID: 24608202
[TBL] [Abstract][Full Text] [Related]
6. A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer.
Nelson SE; Gould MN; Hampton JM; Trentham-Dietz A
Breast Cancer Res; 2005; 7(3):R357-64. PubMed ID: 15987431
[TBL] [Abstract][Full Text] [Related]
7. HER2 Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer.
Ozturk O; Canbay E; Kahraman OT; Fatih Seyhan M; Aydogan F; Celik V; Uras C
Mol Biol Rep; 2013 Feb; 40(2):1813-8. PubMed ID: 23086302
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes.
Vitiello GAF; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE
Breast Cancer Res Treat; 2019 Nov; 178(1):207-219. PubMed ID: 31364002
[TBL] [Abstract][Full Text] [Related]
9. Involvement of INF-γ functional single nucleotide polymorphism +874 T/A (rs2430561) in breast cancer risk.
Al-Rashidi HE; Refaat S; Ahmed E; Hussein DT; Eltantawy FM; Hamed S
Saudi J Biol Sci; 2021 Nov; 28(11):6289-6296. PubMed ID: 34759748
[TBL] [Abstract][Full Text] [Related]
10. Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: a systematic review and meta-analysis.
Dahabreh IJ; Murray S
Cancer Epidemiol; 2011 Dec; 35(6):503-9. PubMed ID: 21474413
[TBL] [Abstract][Full Text] [Related]
11. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.
Bayram S; Sümbül AT; Dadaş E
Tumour Biol; 2016 Apr; 37(4):5577-84. PubMed ID: 26577852
[TBL] [Abstract][Full Text] [Related]
12. Role of HER-2 Ile655Val Polymorphism as Universal Cancer Susceptibility Marker among Different Cancers.
Riaz SK; Rashid MM; Kayani MA; Arshad Malik MF
Arch Iran Med; 2016 Jun; 19(6):430-8. PubMed ID: 27293060
[TBL] [Abstract][Full Text] [Related]
13. HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer.
Mojtahedi Z; Erfani N; Malekzadeh M; Haghshenas MR; Ghaderi A; Samsami Dehaghani A
Iran Red Crescent Med J; 2013 Jan; 15(1):1-3. PubMed ID: 23487505
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis.
Vitiello GAF; Guembarovski RL; Hirata BKB; Amarante MK; de Oliveira CEC; de Oliveira KB; Cebinelli GCM; Guembarovski AL; Campos CZ; Watanabe MAE
J Cancer Res Clin Oncol; 2018 Apr; 144(4):645-655. PubMed ID: 29362917
[TBL] [Abstract][Full Text] [Related]
15. BCL-2 (-938C>A), BAX (-248G>A), and HER2 Ile655Val Polymorphisms and Breast Cancer Risk in Indian Population.
Bhatt D; Verma AK; Bharti PS; Goyal Y; Alsahli MA; Almatroudi A; Rahmani AH; Almatroodi S; Joshi PC; Alam MM; Ahmad I; Zaman GS; Dev K
J Oncol; 2021; 2021():8865624. PubMed ID: 33708254
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors.
Furrer D; Lemieux J; Côté MA; Provencher L; Laflamme C; Barabé F; Jacob S; Michaud A; Diorio C
Breast; 2016 Dec; 30():191-196. PubMed ID: 27788409
[TBL] [Abstract][Full Text] [Related]
17. Association of HER2 codon 655 polymorphism with ovarian cancer.
Watrowski R; Castillo-Tong DC; Schuster E; Fischer MB; Speiser P; Zeillinger R
Tumour Biol; 2016 Jun; 37(6):7239-44. PubMed ID: 26666819
[TBL] [Abstract][Full Text] [Related]
18. ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients.
Madrid-Paredes A; Cañadas-Garre M; Sánchez-Pozo A; Segura-Pérez AM; Chamorro-Santos C; Vergara-Alcaide E; Castillo-Portellano L; Calleja-Hernández MÁ
Pharmacol Res; 2016 Jun; 108():111-118. PubMed ID: 27137881
[TBL] [Abstract][Full Text] [Related]
19. The single nucleotide polymorphism +936 C/T VEGF is associated with human epidermal growth factor receptor 2 expression in Moroccan breast cancer women.
Rahoui J; Sbitti Y; Touil N; Laraqui A; Ibrahimi A; Rhrab B; Al Bouzidi A; Moussaoui Rahali D; Dehayni M; Ichou M; Zaoui F; Mrani S
Med Oncol; 2014 Dec; 31(12):336. PubMed ID: 25412937
[TBL] [Abstract][Full Text] [Related]
20. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
